Investments Opinions The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It. By EQUITY INSIDER Jul 15, 2026 Issued on behalf of Conexeu Sciences Inc.
Investments Opinions The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It. By EQUITY INSIDER Jul 15, 2026 Issued on behalf of Conexeu Sciences Inc.